{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T20:35:55Z","timestamp":1768250155027,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,10,11]],"date-time":"2010-10-11T00:00:00Z","timestamp":1286755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,10,11]],"date-time":"2010-10-11T00:00:00Z","timestamp":1286755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1038\/bmt.2010.240","type":"journal-article","created":{"date-parts":[[2010,10,11]],"date-time":"2010-10-11T10:48:24Z","timestamp":1286794104000},"page":"1145-1147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Risks and benefits of ovarian shielding in female patients undergoing TBI: a decision analysis"],"prefix":"10.1038","volume":"46","author":[{"given":"Y","family":"Kanda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Ashizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Terasako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S-I","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Kako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,11]]},"reference":[{"key":"BFbmt2010240_CR1","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/bmt.2009.313","volume":"45","author":"B Courbiere","year":"2010","unstructured":"Courbiere B, Prebet T, Mozziconacci MJ, Metzler-Guillemain C, Saias-Magnan J, Gamerre M . Tumor cell contamination in ovarian tissue cryopreserved before gonadotoxic treatment: should we systematically exclude ovarian autograft in a cancer survivor? Bone Marrow Transplant 2010; 45: 1247\u20131248.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010240_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.fertnstert.2006.03.017","volume":"86","author":"K Oktay","year":"2006","unstructured":"Oktay K, Cil AP, Bang H . Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril 2006; 86: 70\u201380.","journal-title":"Fertil Steril"},{"key":"BFbmt2010240_CR3","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/S1472-6483(10)60837-1","volume":"11","author":"M Kuwayama","year":"2005","unstructured":"Kuwayama M, Vajta G, Kato O, Leibo SP . Highly efficient vitrification method for cryopreservation of human oocytes. Reprod BioMed Online 2005; 11: 300\u2013308.","journal-title":"Reprod BioMed Online"},{"key":"BFbmt2010240_CR4","doi-asserted-by":"crossref","unstructured":"Ovarian tissue and oocyte cryopreservation. Fertil Steril 2008; 90: S241\u2013S246.","DOI":"10.1016\/j.fertnstert.2008.08.039"},{"key":"BFbmt2010240_CR5","first-page":"CR91","volume":"11","author":"T Nagashima","year":"2005","unstructured":"Nagashima T, Muroi K, Kawano-Yamamoto C, Miyoshi T, Ohmine K, Toshima M et al. Autologous gamete cryopreservation before hemopoietic stem cell transplantation. Med Sci Monit 2005; 11: CR91\u2013CR94.","journal-title":"Med Sci Monit"},{"key":"BFbmt2010240_CR6","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1182\/blood-2002-07-2231","volume":"101","author":"G Socie","year":"2003","unstructured":"Socie G, Salooja N, Cohen A, Rovelli A, Carreras E, Locasciulli A et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood 2003; 101: 3373\u20133385.","journal-title":"Blood"},{"key":"BFbmt2010240_CR7","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/bmt.2008.234","volume":"42","author":"K Nakagawa","year":"2008","unstructured":"Nakagawa K, Kanda Y, Yamashita H, Nakagawa S, Sasano N, Ohtomo K et al. Ovarian shielding allows ovarian recovery and normal birth in female hematopoietic SCT recipients undergoing TBI. Bone Marrow Transplant 2008; 42: 697\u2013699.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010240_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/bmt.2008.309","volume":"43","author":"S Okuda","year":"2009","unstructured":"Okuda S, Sato M, Terasako K, Kako S, Oshima K, Kanda Y . Should busulfan-containing regimen be avoided for young female patients undergoing hematopoietic stem cell transplantation? Bone Marrow Transplant 2009; 43: 261\u2013262.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010240_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/sj.leu.2404010","volume":"20","author":"BL Scott","year":"2006","unstructured":"Scott BL, Sandmaier BM, Storer B, Maris MB, Sorror ML, Maloney DG et al. Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis. Leukemia 2006; 20: 128\u2013135.","journal-title":"Leukemia"},{"key":"BFbmt2010240_CR10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1532\/IJH97.03166","volume":"79","author":"H Ogawa","year":"2004","unstructured":"Ogawa H, Ikegame K, Kawakami M, Takahashi S, Sakamaki H, Karasuno T et al. Impact of cytogenetics on outcome of stem cell transplantation for acute myeloid leukemia in first remission: a large-scale retrospective analysis of data from the Japan Society for Hematopoietic Cell Transplantation. Int J Hematol 2004; 79: 495\u2013500.","journal-title":"Int J Hematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2010240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2010240","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2010240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T13:11:56Z","timestamp":1648041116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2010240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,11]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["BFbmt2010240"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2010.240","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,11]]},"assertion":[{"value":"11 October 2010","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}